-
Axitinib, sold
under the
brand name Inlyta, is a
small molecule tyrosine kinase inhibitor developed by Pfizer. It has been
shown to
significantly inhibit...
- This is a list of
adverse effects of the anti-cancer drug
axitinib,
sorted by
frequency of occurrence. Very
common (>10% incidence)
adverse effects include:...
- BCR-ABL
kinase translation and
promoting its
degradation by protease.
Axitinib, a drug used to
treat renal cell carcinoma, has been
shown to be effective...
-
inhibit the
tyrosine kinases stimulated by VEGF: sunitinib, sorafenib,
axitinib, and
pazopanib (some of
these therapies target VEGF
receptors rather than...
- sofosbuvir/daclatasvir, osimertinib, crizotinib, daclatasvir, sofosbuvir, afatinib,
axitinib, brigatinib, baricitinib, cabozantinib, dasatinib, neratinib, eltrombopag...
-
biological therapies such as everolimus, torisel, nexavar, sutent, and
axitinib, the use of
immunotherapy including interferon and interleukin-2. Immunotherapy...
- Platelet-derived
growth factor (A, B, C, D)
Kinase inhibitors:
Agerafenib Avapritinib Axitinib Crenolanib Imatinib Lenvatinib Masitinib Motesanib Nintedanib Pazopanib...
- and
locally advanced differentiated thyroid cancer (DTC).
Pazopanib and
axitinib are used
orally for the
treatment of
advanced renal cell carcinoma. Cabozantinib...
-
progression of the
cancer than pembrolizumab,
axitinib and avelumab. In
comparison to
pembrolizumab and
axitinib, it
probably results in more death, but it...
- Platelet-derived
growth factor (A, B, C, D)
Kinase inhibitors:
Agerafenib Avapritinib Axitinib Crenolanib Imatinib Lenvatinib Masitinib Motesanib Nintedanib Pazopanib...
